More than a quarter of emergency contraceptives in Peru falsified or substandard

April 18, 2014
This is a suspected falsified medication that was shipped to Fernandez's lab for analysis. Credit: Rob Felt

A survey of emergency contraceptive pills in Peru found that 28 percent of the batches studied were either of substandard quality or falsified. Many pills released the active ingredient too slowly. Others had the wrong active ingredient. One batch had no active ingredient at all.

To detect the fake drugs, researchers at the Georgia Institute of Technology developed a sophisticated approach using mass spectrometry to quickly assess suspected counterfeit drugs and then characterize their . The study's results highlight a growing concern for women's health in developing nations.

"A woman who does not want to get pregnant and takes these emergency contraceptives will get pregnant," said Facundo M. Fernández, a professor in the School of Chemistry and Biochemistry, whose lab investigated the contraceptives.

The study was sponsored by the ACT Consortium through a grant from the Bill and Melinda Gates Foundation. The study was published April 18 in the journal PLOS ONE.

Drugs are considered fake or falsified when someone makes a pirate copy of copies a patented , with criminal intent. Recent research has found that falsified drugs are a major problem in developing countries. Falsified emergency contraceptives have been reported in Nigeria, Ghana, Kenya, Angola, South America and even the United States. Fake drug manufacturers will copy everything from the pill to the package.

Just as concerning as counterfeit medications are other poor quality medications, such as degraded or substandard drugs. Degraded drugs were once good quality, but lost their efficacy over time, for example after prolonged exposure to the sun in an open air market. Substandard drugs are made by an approved factory, but they don't contain the right , contain less active ingredient than they should, or might not dissolve properly. These pills either result from factory error or negligence.

Falsified drugs are the most worrisome, because they may not contain the expected active ingredient, or they may contain the wrong ingredients, including toxic compounds.

In the survey of emergency contraceptives from Peru, the researchers found that seven of the 25 batches analyzed had inadequate release of the active ingredient (levonorgestrel). One batch had no detectable level of the active ingredient.

"We detected that the active ingredient was not there in one batch, instead those samples had a drug called sulfamethoxazole," Fernandez said. "It's a very common antibiotic. It can cause serious adverse reactions in some patients."

Facundo M. Fernandez, a professor in the School of Chemistry and Biochemistry, examines an emergency contraceptive pill with ambient mass spectrometry. Credit: Rob Felt

For the study, samples of were purchased at 15 pharmacies and distributors in Lima, Peru, with 60 tables purchased per sample. Tablets were collected from 25 different product batches encompassing 20 brands labeled as manufactured in nine countries (Argentina, Chile, China, Colombia, Hungary, India, Pakistan, Peru and Uruguay).

Analyzing these samples is time consuming and costly with standard tools, so Fernandez's lab developed a method for a quick screen to identify problematic pills. The first-pass screen then allows the researchers to focus a sophisticated analysis on drugs that are suspected fakes. The drugs that pass the screen will still be closely analyzed, but after the suspected fakes.

Fernandez's lab used a tool called ambient mass spectrometry. Scientists in the lab grasp a tablet with a pair of tweezers and swing it front of the instrument to get a real-time signature of the tablet's chemical composition.

"Very quickly we pick out which ones are the problems," Fernandez said.

Their analysis is a tiered-approach. First they look for the presence and identity of the active ingredient. Then they look to see if the right amount is present. Then they test if the pill properly dissolves. Many sophisticated fake pills might pass all these tests, so the scientists also look at the filler in the pills, known as the excipients, such as lactose and cellulose.

"Many fakes are very sophisticated. They have the right active ingredient and they may even have the right amount, but the excipients or coatings may not be the right ones," Fernandez said.

His students have processed thousands of samples and can spot many fake pills before performing the analysis.

"They touch it a bit with their nails and they try to cut into it and they know it's like a rock, just way too hard," Fernandez said. "The tablets are sometimes so hard that they won't dissolve. That's something that you pick up pretty quickly."

Fernandez's lab is working to make these tools portable so that researchers might be able to do these analyses in the field.

"You really want to catch these fakes early, at the customs level or at the distribution center level," Fernandez said. "You don't want to wait for this to get to the pharmacy or for somebody to report it."

Explore further: Fake drugs labelled as Chinese tea: France in record haul (Update)

More information: María Eugenia Monge, et al., "A Tiered Analytical Approach for Investigating Poor Quality Emergency Contraceptives." (PLOS ONE, April 2014) dx.plos.org/10.1371/journal.pone.0095353

Related Stories

Fake drugs labelled as Chinese tea: France in record haul (Update)

April 10, 2014
Aspirin, anti-diarrhoea and erectile dysfunction drugs: French customs have seized millions of counterfeit medicines imported from China in what they described as the biggest haul of its kind within the European Union.

New technology combats global pandemic of drug counterfeiting

August 19, 2012
Drug counterfeiting is so common in some developing countries that patients with serious diseases in Southeast Asia and elsewhere are at risk of getting a poor-quality drug instead of one with ingredients that really treat ...

Simple new test to combat counterfeit drug problem in developing countries

August 19, 2012
In a thrust against the major problem of counterfeit medicines sold in developing countries, which causes thousands of illnesses and deaths annually, scientists today described development of a simple, paper-strip test that ...

FDA device will screen for fake medicines overseas

April 24, 2013
U.S. health officials are making a high-tech screening device available to African authorities to help spot counterfeit malaria pills in hopes that the technology may eventually be used to combat the fake drug trade worldwide.

Report: Tracking system needed to fight fake drugs

February 13, 2013
(AP)—A new report calls for a national drug tracking system to fight the growing problem of fake drugs.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.